LSAE Publication Sources Tool
Displaying 276 - 300 of 328
The LSAE Publication Data Input Sources Tool lets you explore the input sources used for LSAE publications and retrieve relevant metadata about these sources.
Select a publication from the menu and click "Apply" to view and access GHDx catalog records for input sources used for the publication. Click "Reset" to clear the results.
After you've made a selection, download the input sources as a CSV file containing additional metadata. Download this file by clicking the orange "CSV" button in the bottom-left corner of the page.
-
Targema CN. Studies on the status of Bancroftian filariasis in parts of Benue state, Nigeria [dissertation]. Jos, Nigeria: University of Jos, 2010.
-
Taleo F, Taleo G, Graves PM, Wood P, Kim SH, Ozaki M, Joseph H, Chu B, Pavluck A, Yajima A, Melrose W, Ichimori K, Capuano C. Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu. Trop Med Health. 2017; 45: 18.
-
Chandrasena NTGA, Premaratna R, Samarasekera DS, Silva D, R N. Surveillance for transmission of lymphatic filariasis in Colombo and Gampaha districts of Sri Lanka following mass drug administration. Trans R Soc Trop Med Hyg. 2016; 110(10): 620-2.
-
Moustafa MA, Thabet HS, Saad GA, El-Setouhy M, Mehrez M, Hamdy DM. Surveillance of lymphatic filariasis 5 years after stopping mass drug administration in Menoufiya Governorate, Egypt. East Mediterr Health J. 2014; 20(5): 295-9.
-
Adhikari R, Bhusal K. Surveillance of lymphatic filariasis in selected districts of Nepal. J Inst Med. 2008; 35-40.
-
Korte RL, Fontes G, Camargo Jde S, Rocha EM, Araújo EA, Oliveira MZ, Santos RV, Camargo LM. Survey of Bancroftian filariasis infection in humans and Culex mosquitoes in the western Brazilian Amazon region: implications for transmission and control. Rev Soc Bras Med Trop. 2013; 46.0(2): 214-20.
-
Njenga SM, Mwandawiro CS, Wamae CN, Mukoko DA, Omar AA, Shimada M, Bockarie MJ, Molyneux DH. Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control. Parasites Vectors. 2011; 90.
-
Rao RU, Samarasekera SD, Nagodavithana KC, Punchihewa MW, Ranasinghe USB, Weil GJ. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka. PLoS Negl Trop Dis. 2019; 13(4): e0007365.
-
Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN), Ministry of Health, Community Development, Gender, Elderly and Children (MoHCDEC) (Tanzania), World Health Organization Regional Office for Africa (WHO-AFRO). Tanzania Lymphatic Filariasis Site Level Map Data 1925-2023. Brazzaville, Congo: World Health Organization Regional Office for Africa (WHO-AFRO), 2018.
-
Simonsen PE, Meyrowitsch DW, Mukoko DA, Pedersen EM, Malecela-Lazaro MN, Rwegoshora RT, Ouma JH, Masese N, Jaoko WG, Michael E. The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity. Am J Trop Med Hyg. 2004; 70(1): 63-71.
-
Medeiros Z, Bonfim C, Alves A, Oliveira C, Netto MJE, Aguiar-Santos AM. The epidemiological delimitation of lymphatic filariasis in an endemic area of Brazil, 41 years after the first recorded case. Ann Trop Med Parasitol. 2008; 102(6): 509-19.
-
Ngwira BMM, Tambala P, Maria AM, Bowie C, Molyneux DH. The geographical distribution of lymphatic filariasis infection in Malawi. Filaria J. 2007; 6.: 12-12.
-
Esterre P, Plichart C, Sechan Y, Nguyen NL. The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Trop Med Int Health. 2001; 6(3): 190-5.
-
Ashton RA, Kyabayinze DJ, Opio T, Auma A, Edwards T, Matwale G, Onapa A, Brooker S, Kolaczinski JH. The impact of mass drug administration and long-lasting insecticidal net distribution on Wuchereria bancrofti infection in humans and mosquitoes: an observational study in northern Uganda. Parasites Vectors. 2011; 134.
-
Weil GJ, Kastens W, Susapu M, Laney SJ, Williams SA, King CL, Kazura JW, Bockarie MJ. The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea. PLoS Negl Trop Dis. 2008; 2(12): e344.
-
Ramzy RMR, el-Setouhy M, Helmy H, Kandil AM, Ahmed ES, Farid HA, Faris R, Weil GJ. The impact of single-dose diethylcarbamazine treatment of bancroftian filariasis in a low-endemicity setting in Egypt. Am J Trop Med Hyg. 2002; 67(2): 196-200.
-
Coulibaly YI, Dembele B, Diallo AA, Konaté S, Dolo H, Coulibaly SY, Doumbia SS, Soumaoro L, Coulibaly ME, Bockarie MJ, Molyneux D, Nutman TB, Klion AD, Toure YT, Traore SF. The Impact of Six Annual Rounds of Mass Drug Administration on Wuchereria bancrofti Infections in Humans and in Mosquitoes in Mali. Am J Trop Med Hyg. 2015; 93.0(2): 356-60.
-
Pion SD, Chesnais CB, Bopda J, Louya F, Fischer PU, Majewski AC, Weil GJ, Boussinesq M, Missamou F. The impact of two semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo. Am J Trop Med Hyg. 2015; 92(5): 959-66.
-
Sapak P, Williams G. The influence of bed nets on Bancroftian Filariasis in Buhutu Valley, Papua New Guinea. Pac Health Dialog. 1997; 4(1): 35-8.
-
Luroni LT, Gabriel M, Tukahebwa E, Onapa AW, Tinkitina B, Tukesiga E, Nyaraga M, Auma AM, Habomugisha P, Byamukama E, Oguttu D, Katabarwa M, Unnasch TR. The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda. PLoS One. 2017; 12(12): e0189306.
-
De Rochars MB, Kanjilal S, Direny AN, Radday J, Lafontant JG, Mathieu E, Rheingans RD, Haddix AC, Streit TG, Beach MJ, Addiss DG, Lammie PJ. The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration. Am J Trop Med Hyg. 2005; 73(5): 888-94.
-
Medeiros Z, Alves A, Brito JA, Borba L, Santos Z, Costa JP, do Espírito Santo ME, Netto MJE. The present situation regarding lymphatic filariasis in Cabo de Santo Agostinho, Pernambuco, Northeast Brazil. Rev Inst Med Trop Sao Paulo. 2006; 48(5): 263-7.
-
Ginandjar P, Saraswati LD, Suparyanto D, Sakundarno M, Supali T. The Prevalence of Lymphatic Filariasis in Elementary School Children Living in Endemic Areas: A Baseline Survey Prior to Mass Drug Administration in Pekalongan District-Indonesia. Iran J Public Health. 2018; 47(10): 1484-1492.
-
Dickson BFR, Graves PM, Aye NN, Nwe TW, Wai T, Win SS, Shwe M, Douglass J, Bradbury RS, McBride WJ. The prevalence of lymphatic filariasis infection and disease following six rounds of mass drug administration in Mandalay Region, Myanmar. PLoS Negl Trop Dis. 2018; 12(11): e0006944.
-
Weil GJ, Bogus J, Christian M, Dubray C, Djuardi Y, Fischer PU, Goss CW, Hardy M, Jambulingam P, King CL, Kuttiat VS, Krishnamoorthy K, Laman M, Lemoine JF, O'Brian KK, Robinson LJ, Samuela J, Schechtman KB, Sircar A, Srividya A, Steer AC, Supali T, Subramanian S, DOLF IDA Safety Study Group. The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study. PLoS Med. 2019; 16(6): e1002839.
Pages
